NRX Pharmaceuticals, Inc. - 10-Q Filing
NRX Pharmaceuticals reports Q3 2026 financial results with total assets of $50.0M and total liabilities of $12.0M.
Tickers: $NRXP
NRX Pharmaceuticals reports Q3 2026 financial results with total assets of $50.0M and total liabilities of $12.0M.
Tickers: $NRXP